For its 12th edition, BioAsia 2015 has partnered with Organisation of Pharmaceutical Producers of India (OPPI) for identifying new market trends and leveraging cost effective supply chain management in the area of biotechnology and life sciences sector in the country.
With this partnership, the organisers have got an additional booster shot and are fast gearing up to hold this Annual International Life Sciences conference from 2-4 Febraury in Hyderabad.
With India poised to become a power house for the global life sciences sector, this edition of the conference focuses on the new opportunities that lie ahead for the sector spurring meaningful discussions amongst industry leaders, innovators, policy makers, researchers and investors in gearing up for this transition.
With the support from OPPI, BioAsia 2015 will enable companies to identify new emerging market trends for a cost effective pharma supply chain management. The conference will have speakers from the industry along with domain experts including Prof Saral Mukerjee, IIM (A) who will share their insights and knowledge on the role of supply chain in this sector.
As per partnership agreement OPPI will support BioAsia with contemporary topics for discussion covering newer models of supply system, traceability of drugs and anti counterfeiting, implementation of GST and the way forward. Sharing a global perspective of the US and European market, the conference will provide insights to Indian companies on efficient and effective supply chain models.
Today, companies in India spend 10-15 times the percentage of sales on supply chain in comparison with the US and European markets which spend only 2 to 3 times the percentage share under logistics and supply chain costs.
Speaking on the partnership. Shakthi Nagappan, CEO, BioAsia said, “As Indian companies look to expand, penetrate and supply to global markets, an agile, customised and cost-efficient supply chain is of paramount importance. Particularly given the emphasis of Government of India for promoting manufacturing in India and much appreciated the Make in India Campaign, strengthening and building efficient supply chain will be critical to the success of such initiatives.”
Ranjana Smetacek, director general, OPPI said, “Supply chain optimisation, from a cost, quality and overall integrity is perspective critical for the pharmaceutical industry. Rapid technological advancements and innovations will improve the industry’s ability to keep pace with the discerning market and also ensures alignment with global standards.”
As the Telangana State Government has envisaged building a Pharma City in the vicinity of Hyderabad and given the projected growth of pharma manufacturing in the State, the building resilient and sustainable supply chain and logistics mechanism is be absolutely critical.